T his issue of American Journal of Rhinology and Allergy (AJRA) covers a diverse selection of articles on basic and clinical aspects of inflammatory diseases of the upper airways. One such disease, chronic rhinosinusitis (CRS), significantly lowers quality of life. Despite recent progress, however, CRS remains poorly understood. A few of the articles in this AJRA issue focus on the pathophysiology of CRS.
The literature indicates a role for prostaglandin-E2 and E-prostanoid (EP) receptors in CRS. When comparing EP receptors in CRS subtypes, Xie et al. 1 found enhanced EP1 receptor messenger RNA (mRNA) and protein expression in eosinophilic CRS with nasal polyps (CRSwNP). However, EP4 mRNA levels were higher than EP1, EP2, and EP3 levels in controls; in CRS without nasal polyps (CRSsNP); and in noneosinophilic CRSwNP. 1 Nasal tissue eosinophilia is a hallmark of CRSwNP, especially in patients from Western countries. Results of studies have shown an association between tissue eosinophilia and polyp recurrence. In their retrospective analysis from China of 387 patients with CRSwNP, Lou et al. 2 found a significant correlation between tissue eosinophilia and polyp recurrence. They showed that tissue eosinophils Ͼ27% of total cells or a tissue eosinophil absolute count of Ն55 eosinophils per high power field is a reliable prognostic indicator for nasal polyp recurrence within 2 years after surgery. 2 CRS has been linked to imbalances in the production of eicosanoids (arachidonic acid metabolites), which results from phospholipid hydrolysis by phospholipase A2 (PLA2). Mruwat et al. 3 investigated the expression of PLA2s and multiple cytokines in super-antigen Staphylococcus aureus enterotoxin stimulated human nasal polyps from patients with CRSwNP. Stimulation of nasal polyp cells by S. aureus enterotoxin induced cytokine secretion and enhanced expression of several secretory PLA2 and calciumindependent PLA2, while suppressing cytoplasmic PLA2 expression. This supports a role for secretory PLA2s in the pathophysiology of CRS. 3 Wang et al. 4 evaluated the ethmoid bone tissue samples from a group of patients with CRS by histologic examination and quantitative real-time reverse transcription polymerase chain reaction and showed an increased infiltration of eosinophils in the periosteum, along with neo-osteogenesis in CRS. The investigators found increased expression of TGF-␤1, TGF-␤ receptor I, and p-Smad3 in patients with CRSwNP compared with CRSsNP at the mRNA and protein levels. The investigators concluded that these findings were indicative of a potential role for eosinophils in the bone remodeling process in CRSwNP. 4 Oral steroids are used routinely in the management of CRS. However, providers should be aware of potential adverse effects and complications with these medications. In this issue of AJRA, Poetker 5 comprehensively reviews existing data on the risks of oral steroids and discusses the use of oral steroids in CRS.
With the recent emergence of electronic medical records, investigators tend to study large-scale electronic health data bases because of their large sample sizes and accessibility. However, there is a risk of inaccurate cohort identification that can bias the results. In a system-atic review, Lui and Rudmik 6 discussed current case definitions and the various administrative data bases used for CRS research. In Ovid Medline (Ovid Technologies, New York, NY) EMBASE (Elsevier, Atlanta, GA), and EBM, they found 27 studies that had obtained CRS-specific data from a health records data base. Eight different definitions for CRS were used in these studies. Based on this systematic review, there is a clear need for a validated ICD-based CRS case definition to increase the accuracy of future epidemiologic research in this field. 6 Outcomes for some surgical procedures are affected by the day of the week that the procedure is performed. Sedaghat et al. 7 evaluated the association of the day of the week on the outcome of endoscopic sinus surgery (ESS) in a retrospective cohort of 544 patients with CRS. The day of the week that ESS was performed did not affect surgical outcomes. 7 This information is useful for preoperative discussions with patients.
In a postmortem study, Beswick et al. 8 investigated the mucosal surface area in the maxillary sinus that is accessible endoscopically via a middle meatal antrostomy(MMA). Microdebriders with different curvatures were placed through MMAson eight cadavers, and the surface area and volume of the region accessible to each microdebrider tip was calculated. Microdebriders with increasing curvatures allowed for greater access to the maxillary sinus mucosa through MMAs. However, no single curvature or combination of curvatures reached the entirety of the maxillary sinus wall. 8 Halderman et al. 9 did an on-line survey to evaluate the opinion of rhinologists regarding use of balloon catheter dilatation (BCT) in the management of paranasal sinus diseases in CRS and recurrent acute rhinosinusitis. Twenty-five percent (n ϭ 231) of the members of the American Rhinologic Society responded. BCT played no role in the practices of one-third of the respondents. Although BCT use was similar in private practice versus academia, the former group was more satisfied with BCT results. Private practice surgeons used this technology more for maxillary and sphenoid sinuses. It appears that, compared with 5 years ago, rhinologists are more accepting of this method. 9 Cystic fibrosis (CF) is a disease with multiple infectious and inflammatory complications, including CRS. Two studies in this issue of AJRA address clinical and pathologic aspects of this association. A study by Wentzel et al. 10 of a cohort (n ϭ 50) of pediatric patients with CF (2-12 years old) by using the Sinus-and-Nasal-Quality-of-Life-Survey (SN-5) investigated baseline sinonasal quality-of-life scores. Average SN-5 scores of children with CF was lower than published SN-5 averages in children with CRS. SN-5 scores were significantly correlated with recent episodes of sinusitis, antibiotic prescriptions for sinusitis, and number of days missed from school or recreational activities due to sinonasal symptoms. 10 Jeong et al. 11 controls, and a trend, relative to controls, toward reduced carbacholstimulated secretion in CRS subjects with and without CF. 11 Olfactory dysfunction is a major complication of multiple upper airway inflammatory diseases such as allergic rhinitis (AR) and CRS. Altun and Hanci 12 evaluated the effect of nasal septal perforation repair by using a "cross-stealing" technique on improvements in olfactory dysfunction in 42 patients. Smell was measured by SniffinЈ Sticks Extended Test kits. The technique's success rate was 92.8% and resulted in improved olfactory function scores 1, 3, and 6 months after the procedure. 12 The second article on olfactory dysfunction is by Altundag et al. 13 who developed a cross-cultural adaptation of the University of Pennsylvania Smell Identification Test (UPSIT) and investigated its applicability in 51 healthy Turkish subjects. The modified version increased the identification rates of test odorants, which indicated that the UPSIT-T modification is a reliable tool for clinical use in a Turkish population. 13 Olfactory loss is a reported complication after transnasal endoscopic pituitary surgery. Chaaban et al. 14 followed up 18 patients who underwent endoscopic transnasal pituitary surgery. The UPSIT was administered before surgery and 3-4 months after surgery. They found no significant difference between pre-and postoperative scores. The use of nasoseptal flaps did not adversely affect postoperative scores.
Non-AR is a common inflammatory condition. Unfortunately, current medical treatments do not cause satisfactory symptom reduction in a large proportion of affected patients. Yu et al. 15 evaluated the efficacy of radiofrequency turbinate surgery for treatment of refractory non-AR in 35 elderly patients. The response rate for primary radiofrequency turbinate surgery was 68.6%, with significant improvement of rhinorrhea and nasal obstruction and no major complications. 15 Kirtsreesakul et al. 16 evaluated the efficacy of intranasal steroids in 82 patients with AR and 67 patients without AR. 16 The non-AR group was divided into inflammatory non-AR and noninflammatory non-AR groups. The inflammatory non-AR group was subdivided into four phenotypes according to inflammatory-cell type. All the patients used 220 mcg of nasal triamcinolone acetonide once daily. Although both patients in the AR group and those in the non-AR group had significant reduction of symptoms, the non-AR group had less improvement in nasal symptoms than the AR group. Among patients in the non-AR group, noninflammatory cases had the worst treatment outcomes. 16 Indolamine-2,3-dioxygenase is a metabolic enzyme induced by immune activation. Refaat et al. 17 found a significant increase in indolamine-2,3-dioxygenase levels in allergic rhinitis compared with subjects without allergy. Indolamine-2,3-dioxygenase was positively correlated with total serum IgE levels. 17 Choosing between skin-prick tests and in vitro blood tests to evaluate aeroallergen sensitivity in chronic rhinitis is an important decision. In a comprehensive review, Oppenheimer 18 discusses concerns and advantages of each test that can help clinicians make the right choice in various clinical scenarios.
The dust mite is one of the most common perennial aeroallergens that cause significant upper-and lower-respiratory symptoms in individuals with allergy. Li et al. 19 examined the efficacy of a pollen blocker cream in a multicenter randomized double-blind placebocontrolled, crossover trial in a Chinese population. The cream was applied to the lower internal nose region three times daily for 30 days. The cream decreased nasal symptoms compared with placebo. No severe systemic reaction was observed, and adverse events were similar.
Stoddard et al. 20 prospectively examined the effect of trimming nasal vibrissae (the stiff hair in anterior nares) on subjective and objective measures of nasal obstruction in 30 healthy individuals. They found, after trimming the vibrissae, improvement in both nasal airway symptom scores and objective measurements of the nasal airway. Further studies are needed to investigate the effect of trimming vibrissae in diseases associated with nasal obstruction.
Two articles on nasal cavity neoplasms are published in this AJRA issue. The first covers an important epidemiologic predictor of survival in esthesioneuroblastoma (ENB). ENB is a rare neoplasm that originates from olfactory neuroepithelium. In a large epidemiologic study based on the Surveillance Epidemiology and End Results data base, Stokes et al. 21 found that male sex is a risk factor for significantly worse disease-specific 10-year survival in patients with ENB. This appears to be due to higher grade and stage in male patients at presentation. 21 In the second article, Craig et al. 22 reported results of their experience, along with a review of published cases to compare different endonasal endoscopic resection techniques in treating extraconal and intraconal orbital-apex tumors. Two-and four-handed techniques were used to resect these pathologies for both benign and malignant tumors. Either endonasal or combined endonasal-orbital approaches can be used in four-handed surgeries. The strongest predictor of complete resection was benign pathology, regardless of technique. They concluded that benign tumors can be treated by either two-or four-handed endonasal techniques and that the choice should be based on the surgeon's experience. 22 In this AJRA issue's "How I do it" article, Knisely et al. 23 shared their experiences and procedures in performing Draf III frontal sinusotomy or modified Lothrop surgery to treat conditions, including recalcitrant rhinosinusitis, frontal sinus mucoceles, and frontal sinus tumors.
We hope you enjoy reading the September-October issue of AJRA. This issue contains a rich and diverse array of articles that can advance our knowledge in different aspects of sinonasal diseases. 
